Abstract
Transient ischemic attack (TIA) presents a high risk for subsequent stroke, Alzheimer’s disease (AD), and related dementia (ADRD). However, the neuropathophysiology of TIA has been rarely studied. By evaluating recurrent TIA-induced neuropathological changes, our study aimed to explore the potential mechanisms underlying the contribution of TIA to ADRD. In the current study, we established a recurrent TIA model by three times 10-min middle cerebral artery occlusion within a week in rat. Neither permanent neurological deficit nor apoptosis was observed following recurrent TIA. No increase of AD-related biomarkers was indicated after TIA, including increase of tau hyperphosphorylation and β-site APP cleaving enzyme 1 (BACE1). Neuronal cytoskeleton modification and neuroinflammation was found at 1, 3, and 7 days after recurrent TIA, evidenced by the reduction of microtubule-associated protein 2 (MAP2), elevation of neurofilament-light chain (NFL), and increase of glial fibrillary acidic protein (GFAP)-positive astrocytes and ionized calcium binding adaptor molecule 1 (Iba1)-positive microglia at the TIA-affected cerebral cortex and basal ganglion. Similar NFL, GFAP and Iba1 alteration was found in the white matter of corpus callosum. In summary, the current study demonstrated that recurrent TIA may trigger neuronal cytoskeleton change, astrogliosis, and microgliosis without induction of cell death at the acute and subacute stage. Our study indicates that TIA-induced neuronal cytoskeleton modification and neuroinflammation may be involved in the vascular contribution to cognitive impairment and dementia.
Similar content being viewed by others
Data Availability
Not applicable.
Abbreviations
- AD:
-
Alzheimer’s disease
- ADRD:
-
Alzheimer’s disease (AD) and related dementia
- BACE1:
-
β-Site APP cleaving enzyme 1
- BG:
-
Basal ganglia
- CX:
-
Cortex
- DWI:
-
Diffusion-weighted imaging
- GFAP:
-
Glial fibrillary acidic protein
- Iba1:
-
Ionized calcium binding adaptor molecule 1
- ICA:
-
Internal carotid artery
- MAP2:
-
Microtubule-associated protein 2
- MBP:
-
Myelin basic protein
- MCAO:
-
Middle cerebral artery occlusion
- NFL:
-
Neurofilament-light chain
- ROI:
-
Regions of interests
- TIA:
-
Transient ischemic attack
- T2WI:
-
T2-weighted imaging
References
Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276–93.
Walz ET, Brink T, Slivka A. Pattern and frequency of recurrent transient ischemic attacks. J Stroke Cerebrovasc Dis. 1997;6(3):121–4.
Khare S. Risk factors of transient ischemic attack: an overview. J Midlife Health. 2016;7(1):2–7.
Purroy F, Jimenez Caballero PE, Gorospe A, et al. Recurrent transient ischaemic attack and early risk of stroke: data from the PROMAPA study. J Neurol Neurosurg Psychiatry. 2013;84(6):596–603.
Zamboni G, Griffanti L, Jenkinson M, et al. White matter imaging correlates of early cognitive impairment detected by the montreal cognitive assessment after transient ischemic attack and minor stroke. Stroke. 2017;48(6):1539–47.
Kalaria RN, Akinyemi R, Ihara M. Does vascular pathology contribute to Alzheimer changes? J Neurol Sci. 2012;322(1–2):141–7.
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–713.
Goulay R, Mena Romo L, Hol EM, et al. From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-beta formation. Transl Stroke Res. 2020;11(4):601–14.
Fazekas F, Fazekas G, Schmidt R, et al. Magnetic resonance imaging correlates of transient cerebral ischemic attacks. Stroke. 1996;27(4):607–11.
Bhadelia RA, Anderson M, Polak JF, et al. Prevalence and associations of MRI-demonstrated brain infarcts in elderly subjects with a history of transient ischemic attack. The Cardiovascular Health Study Stroke. 1999;30(2):383–8.
Ferris JK, Edwards JD, Ma JA, et al. Changes to white matter microstructure in transient ischemic attack: a longitudinal diffusion tensor imaging study. Hum Brain Mapp. 2017;38(11):5795–803.
Simmatis LER, Scott SH, Jin AY. The impact of transient ischemic attack (TIA) on brain and behavior. Front Behav Neurosci. 2019;13:44.
Ejaz S, Emmrich JV, Sawiak SJ, et al. Cortical selective neuronal loss, impaired behavior, and normal magnetic resonance imaging in a new rat model of true transient ischemic attacks. Stroke. 2015;46(4):1084–92.
Wang J, Li Y, Yu H, et al. Dl-3-N-Butylphthalide promotes angiogenesis in an optimized model of transient ischemic attack in C57BL/6 Mice. Front Pharmacol. 2021;12:751397.
Roy Choudhury G, Ryou MG, Poteet E, et al. Involvement of p38 MAPK in reactive astrogliosis induced by ischemic stroke. Brain Res. 2014;10(1551):45–58.
Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation Stroke. 1995;26(4):627–34 (discussion 635).
Schallert T, Fleming SM, Leasure JL, et al. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology. 2000;39(5):777–87.
Shi J, Yang SH, Stubley L, et al. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 2000;853(1):1–4.
Durukan Tolvanen A, Tatlisumak E, Pedrono E, et al. TIA model is attainable in Wistar rats by intraluminal occlusion of the MCA for 10min or shorter. Brain Res. 2017;15(1663):166–73.
Wang J, Zhang P, Tang Z. Animal models of transient ischemic attack: a review. Acta Neurol Belg. 2020;120(2):267–75.
Liu F, McCullough LD. Middle cerebral artery occlusion model in rodents: methods and potential pitfalls. J Biomed Biotechnol. 2011;2011:464701.
Bonnin P, Kubis N, Charriaut-Marlangue C. Collateral supply in preclinical cerebral stroke models. Transl Stroke Res. 2021 Nov 19.
Wolf VL, Ergul A. Progress and challenges in preclinical stroke recovery research. Brain Circ. 2021;7(4):230–40.
Fan C, Zhang L, He Z, et al. Reduced severity of outcome of recurrent ipsilateral transient cerebral ischemia compared with contralateral transient cerebral ischemia in rats. J Stroke Cerebrovasc Dis. 2017;26(12):2915–25.
Jakel L, De Kort AM, Klijn CJM, et al. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(1):10–28.
Govindpani K, McNamara LG, Smith NR, et al. Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it? J Clin Med. 2019 May 10;8(5).
Yang J, Wong A, Wang Z, et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement. 2015;11(1):16–23.
Corriveau RA, Bosetti F, Emr M, et al. The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline. Cell Mol Neurobiol. 2016;36(2):281–8.
Wen Y, Onyewuchi O, Yang S, et al. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res. 2004;1009(1–2):1–8.
Wen Y, Yang S, Liu R, et al. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer’s disease-like tauopathy in female rats. J Biol Chem. 2004;279(21):22684–92.
Wen Y, Yang S, Liu R, et al. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res. 2004;1022(1–2):30–8.
Tesco G, Koh YH, Kang EL, et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron. 2007;54(5):721–37.
Dawson DA, Hallenbeck JM. Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J Cereb Blood Flow Metab. 1996;16(1):170–4.
Hartig W, Krueger M, Hofmann S, et al. Up-regulation of neurofilament light chains is associated with diminished immunoreactivities for MAP2 and tau after ischemic stroke in rodents and in a human case. J Chem Neuroanat. 2016;78:140–8.
Mages B, Fuhs T, Aleithe S, et al. The cytoskeletal elements MAP2 and NF-L show substantial alterations in different stroke models while elevated serum levels highlight especially MAP2 as a sensitive biomarker in stroke patients. Mol Neurobiol. 2021;58(8):4051–69.
Zetterberg H. Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration. Neuron. 2016;91(1):1–3.
Yanagihara T, Brengman JM, Mushynski WE. Differential vulnerability of microtubule components in cerebral ischemia. Acta Neuropathol. 1990;80(5):499–505.
Stassart RM, Mobius W, Nave KA, et al. The axon-myelin unit in development and degenerative disease. Front Neurosci. 2018;12:467.
LoPresti P. Tau in oligodendrocytes takes neurons in sickness and in health. Int J Mol Sci. 2018 Aug 15;19(8)
Seiberlich V, Bauer NG, Schwarz L, et al. Downregulation of the microtubule associated protein tau impairs process outgrowth and myelin basic protein mRNA transport in oligodendrocytes. Glia. 2015;63(9):1621–35.
Lyu J, Jiang X, Leak RK, et al. Microglial responses to brain injury and disease: functional diversity and new opportunities. Transl Stroke Res. 2021;12(3):474–95.
Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32(12):638–47.
Prinz M, Jung S, Priller J. Microglia biology: one century of evolving concepts. Cell. 2019;179(2):292–311.
Askew K, Li K, Olmos-Alonso A, et al. Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain. Cell Rep. 2017;18(2):391–405.
Tariq S, Tsang A, Wang M, et al. White matter tract microstructure and cognitive performance after transient ischemic attack. PLoS ONE. 2020;15(10):e0239116.
Nasrabady SE, Rizvi B, Goldman JE, et al. White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6(1):22.
Nagy M, Azeem MU, Soliman Y, et al. Pre-existing white matter hyperintensity lesion burden and diagnostic certainty of transient ischemic attack. J Stroke Cerebrovasc Dis. 2019;28(4):944–53.
Alber J, Alladi S, Bae HJ, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities. Alzheimers Dement (N Y). 2019;5:107–17.
Munoz-Lasso DC, Roma-Mateo C, Pallardo FV, et al. Much more than a scaffold: cytoskeletal proteins in neurological disorders. Cells. 2020 Feb 4;9(2).
Gaetani L, Blennow K, Calabresi P, et al. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870–81.
Xi G. Clinical translation of cerebral preconditioning. Transl Stroke Res. 2010;1(1):2–3.
Colas-Campas L, Farre J, Mauri-Capdevila G, et al. Inflammatory response of ischemic tolerance in circulating plasma: preconditioning-induced by transient ischemic attack (TIA) phenomena in acute ischemia patients (AIS). Front Neurol. 2020;11:552470.
Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA Study. Stroke. 2004;35(11 Suppl 1):2680–2.
Ghozy S, Kacimi SEO, Elfil M, et al. Transient ischemic attacks preceding ischemic stroke and the possible preconditioning of the human brain: a systematic review and meta-analysis. Front Neurol. 2021;12:755167.
McDonough A, Weinstein JR. The role of microglia in ischemic preconditioning. Glia. 2020;68(3):455–71.
Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23(9):1018–27.
Funding
This work was in part supported by National Institutes of Health grant NS109583 (SY) and a grant (#RP210046) from the Cancer Prevention and Research Institute of Texas (RB).
Author information
Authors and Affiliations
Contributions
LW, RL, and SY conceived and designed the experiments; LW, AW, KC, YS, and RB performed the experiments. LW analyzed the data. LW, CT, RL, and SY wrote and edited the manuscript; all the authors reviewed the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical Approval
All applicable international, national and/or institutional guidelines for the care and use of animals were followed.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, L., Chaudhari, K., Winters, A. et al. Recurrent Transient Ischemic Attack Induces Neural Cytoskeleton Modification and Gliosis in an Experimental Model. Transl. Stroke Res. 14, 740–751 (2023). https://doi.org/10.1007/s12975-022-01068-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-022-01068-7